OPKO Health logo

OPKO Health

North America, Florida, United States, Miami

Description

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.

Investor Profile

OPKO Health has made 6 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series Unknown (33%)
  • Series C (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Genetics
  • Clinical Trials
  • Biopharma
  • Home Health Care
  • Information Technology
  • Mhealth
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OPKO Health frequently co-invest with?

LSP BioVentures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
AC
North America, New York, United States, New York
Co-Investments: 1
DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
BF
North America, Texas, United States, Fort Worth
Co-Investments: 1
Quark Venture
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Catalyst Venture Partners
Europe, Bath and North East Somerset, United Kingdom, Bath
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

Which angels does OPKO Health often collaborate with?

PF
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by OPKO Health?

HealthSnap

Miami, Florida, United States

HealthSnap is a virtual care management platform for chronic disease management.

Health CareHome Health CareInformation TechnologymHealthSoftware
Series UnknownNov 10, 2021
Amount Raised: $5,000,000
Eloxx

Waltham, Massachusetts, United States

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

BiotechnologyGeneticsHealth Care
Series CAug 2, 2017
Amount Raised: $8,000,000
Phio Pharmaceuticals

Marlborough, Massachusetts, United States

Phio Pharmaceuticals is a biotechnology company specializing in the application of RNAi therapies in immuno-oncology.

BiotechnologyHealth CareMedicalOncology
Post Ipo EquityDec 16, 2016
Amount Raised: $10,400,000
VBI Vaccines

Cambridge, Massachusetts, United States

VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.

BiotechnologyClinical TrialsHealth Care
Post Ipo EquityJul 5, 2016
Amount Raised: $13,609,749
Arno Therapeutics

Parsippany, New Jersey, United States

Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.

BiopharmaBiotechnologyMedical
Post Ipo EquityJan 13, 2016
Amount Raised: $7,400,000
Fabrus

La Jolla, California, United States

Fabrus identifies and develops functional therapeutic monoclonal antibodies to challenging cell surface targets like GPCRs and ion channels.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownNov 4, 2010
Amount Raised: $2,000,000